Menu
Back to User profile » Dr Gang Wu
Papers published by Dr Gang Wu:
Antimicrobial and Pro-Osteogenic Coaxially Electrospun Magnesium Oxide Nanoparticles-Polycaprolactone /Parathyroid Hormone-Polycaprolactone Composite Barrier Membrane for Guided Bone Regeneration
Dong Y, Yao L, Cai L, Jin M, Forouzanfar T, Wu L, Liu J, Wu G
International Journal of Nanomedicine 2023, 18:369-383
Published Date: 19 January 2023
The Antagonist of Retinoic Acid Receptor α, ER-50891 Antagonizes the Inhibitive Effect of All-Trans Retinoic Acid and Rescues Bone Morphogenetic Protein 2-Induced Osteoblastogenic Differentiation
Wang S, Bi W, Liu Y, Cheng J, Sun W, Wu G, Xu X
Drug Design, Development and Therapy 2020, 14:297-308
Published Date: 22 January 2020
Epigallocatechin-3-gallate enhances the osteoblastogenic differentiation of human adipose-derived stem cells
Zhang J, Wu K, Xu T, Wu J, Li P, Wang H, Wu H, Wu G
Drug Design, Development and Therapy 2019, 13:1311-1321
Published Date: 23 April 2019
All-trans retinoic acid can antagonize osteoblastogenesis induced by different BMPs irrespective of their dimerization types and dose-efficiencies
Liu Y, Ma X, Guo J, Lin Z, Zhou M, Bi W, Liu J, Wang J, Lu H, Wu G
Drug Design, Development and Therapy 2018, 12:3419-3430
Published Date: 10 October 2018
Mathematical evaluation of the influence of multiple factors on implant stability quotient values in clinical practice: a retrospective study
Huang H, Wismeijer D, Shao X, Wu G
Therapeutics and Clinical Risk Management 2016, 12:1525-1532
Published Date: 11 October 2016
Scaling and root planning and locally delivered minocycline could reduce the load of Prevotella intermedia in an interdependent pattern, which correlated with symptomatic improvements of chronic periodontitis: a short-term randomized clinical trial
Deng S, Wang Y, Sun W, Chen H, Wu G
Therapeutics and Clinical Risk Management 2015, 11:1795-1803
Published Date: 4 December 2015